The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.EBI
Xenon Pharmaceuticals
A thiocarbamate inhibitor of endothelial lipase raises HDL cholesterol levels in mice.EBI
Janssen Research and Development
Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipase.EBI
Novo Nordisk
Benzothiazole-based compounds as potent endothelial lipase inhibitors.EBI
Bristol-Myers Squibb
Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase.EBI
Bristol-Myers Squibb
Sulfonylated Benzothiazoles as Inhibitors of Endothelial Lipase.EBI
Bristol-Myers Squibb
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In Vivo.EBI
TBA
PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor.EBI
Bristol-Myers Squibb